MAS-Seq Supports Isoform Research Using Single-Cell RNA Sequencing from 10x Genomics MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the launch of its Multiplexed Arrays Sequencing (MAS-Seq) kit in partnership with the Broad Institute of MIT and Harvard and 10x Genomics, Inc. The kit is a first-of-its-kind kitted solution leveraging […]

A new HORIBA Chair will work with industry and academia to champion and develop new propulsion technologies, creating the next generation of battery and fuel cell mobility and leading the way towards a cleaner, greener, and carbon-free future. University College London (UCL) researchers are closer to meeting the challenge of developing zero-emission transport, thanks to […]

Initiative to focus on development, manufacture, and validation of publicly available somatic reference samples ARLINGTON, Va. — The Medical Device Innovation Consortium (MDIC) has partnered with PerkinElmer’s Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics. The SRSs are expected to be commercially available […]

Alliance panels include a 50-gene pharmacogenomics panel and a nearly 400-gene panel of challenging, medically relevant “dark genes” developed in collaboration with leading institutions MENLO PARK, Calif. and SOUTH SAN FRANCISCO — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality […]

Agreement will allow researchers to streamline development of on-demand and automated production of CRISPR-Cas9 guide RNA SAN DIEGO — Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and validation of Telesis […]

The Consortium Will Build a Publicly Available Database as a Resource to Accelerate Insights from Long-Read Human Genome Datasets MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the Consortium for Long Read Sequencing (CoLoRS) that aims to accelerate the utility of long-read human genome datasets. CoLoRS is an […]

Marlborough, MA – Innovator in laboratory digital transformation, Scitara, announces a new partnership with Veeva, the global leader in cloud software for the life sciences industry. The partnership will bring together Scitara’s strength in lab instrument solutions with Veeva’s quality assurance (QA) and quality control (QC) software to help companies improve data integrity, maximize lab productivity, […]

Transformative alliance will help advance the World Health Organization’s strategy to end the global TB epidemic by 2035 SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, today announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. The partnership will […]

Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network of nationally recognized laboratories. Now physician-owned laboratories (POLs) that specialize in urology, gastroenterology, or women’s health, can add next-generation sequencing (NGS) testing for hereditary cancer to their routine diagnostic practice. Lowering the […]

New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes. DURHAM, N.C. – BioSkryb Genomics, a pioneer in developing scientifically advanced single-cell analysis molecular tools, today announced a multi-year agreement with Cooper Genomics, a leader in the reproductive health market, to license BioSkryb’s proprietary […]